vs

Side-by-side financial comparison of REPLIGEN CORP (RGEN) and SentinelOne, Inc. (S). Click either name above to swap in a different company.

SentinelOne, Inc. is the larger business by last-quarter revenue ($258.9M vs $197.9M, roughly 1.3× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -23.3%, a 30.0% gap on every dollar of revenue. On growth, SentinelOne, Inc. posted the faster year-over-year revenue change (22.9% vs 13.6%). SentinelOne, Inc. produced more free cash flow last quarter ($20.9M vs $17.6M).

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

SentinelOne, Inc. is an American cybersecurity company listed on NYSE based in Mountain View, California. The company was founded in 2013 by Tomer Weingarten, Almog Cohen and Ehud ("Udi") Shamir. Weingarten acts as the company's CEO. The company has approximately 2,800 employees and offices in Mountain View, Boston, Prague, Tokyo, and Tel Aviv. The company uses machine learning for monitoring personal computers, IoT devices, and cloud workloads. The company's platform utilizes a heuristic mod...

RGEN vs S — Head-to-Head

Bigger by revenue
S
S
1.3× larger
S
$258.9M
$197.9M
RGEN
Growing faster (revenue YoY)
S
S
+9.3% gap
S
22.9%
13.6%
RGEN
Higher net margin
RGEN
RGEN
30.0% more per $
RGEN
6.7%
-23.3%
S
More free cash flow
S
S
$3.4M more FCF
S
$20.9M
$17.6M
RGEN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
RGEN
RGEN
S
S
Revenue
$197.9M
$258.9M
Net Profit
$13.3M
$-60.3M
Gross Margin
52.5%
73.8%
Operating Margin
9.0%
-28.3%
Net Margin
6.7%
-23.3%
Revenue YoY
13.6%
22.9%
Net Profit YoY
143.9%
23.1%
EPS (diluted)
$0.24
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGEN
RGEN
S
S
Q4 25
$197.9M
$258.9M
Q3 25
$188.8M
$242.2M
Q2 25
$182.4M
$229.0M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
RGEN
RGEN
S
S
Q4 25
$13.3M
$-60.3M
Q3 25
$14.9M
$-72.0M
Q2 25
$14.9M
$-208.2M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
RGEN
RGEN
S
S
Q4 25
52.5%
73.8%
Q3 25
53.2%
75.0%
Q2 25
50.0%
75.3%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
RGEN
RGEN
S
S
Q4 25
9.0%
-28.3%
Q3 25
8.9%
-33.3%
Q2 25
7.6%
-38.2%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
RGEN
RGEN
S
S
Q4 25
6.7%
-23.3%
Q3 25
7.9%
-29.7%
Q2 25
8.2%
-90.9%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
RGEN
RGEN
S
S
Q4 25
$0.24
$-0.18
Q3 25
$0.26
$-0.22
Q2 25
$0.26
$-0.63
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGEN
RGEN
S
S
Cash + ST InvestmentsLiquidity on hand
$767.6M
$649.8M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$2.1B
$1.5B
Total Assets
$2.9B
$2.4B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGEN
RGEN
S
S
Q4 25
$767.6M
$649.8M
Q3 25
$748.7M
$810.8M
Q2 25
$708.9M
$766.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
RGEN
RGEN
S
S
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RGEN
RGEN
S
S
Q4 25
$2.1B
$1.5B
Q3 25
$2.1B
$1.5B
Q2 25
$2.1B
$1.5B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
RGEN
RGEN
S
S
Q4 25
$2.9B
$2.4B
Q3 25
$2.9B
$2.4B
Q2 25
$2.9B
$2.4B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
RGEN
RGEN
S
S
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGEN
RGEN
S
S
Operating Cash FlowLast quarter
$25.7M
$21.0M
Free Cash FlowOCF − Capex
$17.6M
$20.9M
FCF MarginFCF / Revenue
8.9%
8.1%
Capex IntensityCapex / Revenue
4.1%
0.0%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGEN
RGEN
S
S
Q4 25
$25.7M
$21.0M
Q3 25
$48.1M
$-1.0M
Q2 25
$28.6M
$52.3M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
RGEN
RGEN
S
S
Q4 25
$17.6M
$20.9M
Q3 25
$43.4M
$-1.3M
Q2 25
$21.5M
$52.1M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
RGEN
RGEN
S
S
Q4 25
8.9%
8.1%
Q3 25
23.0%
-0.5%
Q2 25
11.8%
22.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
RGEN
RGEN
S
S
Q4 25
4.1%
0.0%
Q3 25
2.5%
0.1%
Q2 25
3.9%
0.1%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
RGEN
RGEN
S
S
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RGEN
RGEN

Segment breakdown not available.

S
S

US$154.8M60%
Non Us$104.1M40%

Related Comparisons